Lipopharma Therapeutics
next-generation medicines!
Vicenç Tur. CEO
Address: Ctra. de Valldemossa, Km. 7,4. Parc BIT. Edificio 17, 2n C-8
City: 07121 Palma de Mallorca
Province: Palma de Mallorca
Phone: 34 971 439 886
Fax: 34 971 439 974
Mission and Objectives
Lipopharma is a pioneering biopharmaceutical company that focuses on the discovery, rational design and development of a new generation of medicines associated with a novel therapeutic approach: the Membrane Lipid Therapy (MLT). MLT is the result of breakthrough scientific discoveries that allow us to develop a new class of lipid-regulator therapeutic agents with dramatic game-changing potential in addressing serious and life-threatening conditions with very important clinical needs unmet, like cancer, CNS, inflammatory or metabolic diseases.
Products/Services, Areas of interest for future collaborations/Alliances
2OHOA is a new class of an orally bioavailable specific activator of SMS leading to an increased concentration of SM and DAG in the tumor cell membrane and to a decreased membrane levels of PS, PE and PC. This restores the normal, healthy levels and ratios of membrane lipids, inhibiting membrane-protein associated signaling and the aberrant activity of key signaling pathways (Cyclin D/CDK, Ras/MAPK and PI3K/AKt) in different tumor cells.
A promising MLT-based pipeline is being consolidated, with potential applications in AD, inflammation or Spinal Cord Injury. Lipopharma is seeking new partnerships in order to develop our R&D pipeline.

Lipopharma Therapeutics
Developed by Web4Bio